AOD-9604 5 mg liofilizirana bočica — Peptiva fotografija proizvoda

AOD-9604

5 mg / Lyophilised vial
€60,00
Sale price  €60,00 Regular price 
Skip to product information
AOD-9604 5 mg liofilizirana bočica — Peptiva fotografija proizvoda

Peptiva

AOD-9604

€60,00
Sale price  €60,00 Regular price 
Intensity5 mg
Format

FOR IN VITRO LABORATORY RESEARCH USE ONLY.
Not for personal, clinical, diagnostic or veterinary use. Not for use in humans or animals.

Description and specifications

What is AOD-9604?

AOD-9604 is a modified fragment of the C-terminal region of human growth hormone, developed for researching metabolic effects without the full activity of intact HGH. The literature includes preclinical and limited clinical programs.

Mechanism and Scientific Context

Research focuses on the regulation of fat breakdown and formation in adipocytes. The exact molecular target is not fully elucidated, and results vary between cellular, animal, and clinical models.

Main Areas of Research

  • lipolysis and lipogenesis in fat cells
  • structural regions of growth hormone
  • body composition and metabolic indicators
  • differences between preclinical and clinical outcomes

How to Interpret Research Data?

When reading the literature, check the identity of the material studied, the type of model, and the limitations of the study. The existence of a paper on a molecule does not confirm the properties of this product or its batch. Findings from laboratory and animal models do not prove clinical benefit.

Available Peptiva Variants

  • 5 mg · Lyophilized vial
  • 5 mg · Research dispenser

Select the available variant and check its name, total content, and price. The photo is not a substitute for the declaration of the selected variant.

Format and Package Contents

Research dispenser: The variant contains a fully filled dispenser with the selected content, not just a separate replacement cartridge. The quantity listed with the variant refers to the total declared content, not the amount per single use.

Lyophilized vial: The variant contains lyophilized material in a vial, without a dispenser. This description does not refer to bacteriostatic water or a separate empty container.

Storage and handling conditions depend on the specific formulation and batch declaration. The packaging format does not confirm sterility, dosing precision, stability, or suitability for human or animal use.

Important Limitations

There is insufficient evidence for promises of weight reduction. The product is intended exclusively for research comparison.

Batch Documentation

For inquiries about available COA documentation, please contact peptivacomhr@gmail.com with the product name and LOT number if known. Availability and scope of analyses are checked for the specific batch. A COA does not inherently prove sterility or suitability for human or animal use.

Purpose and Limitations: The product is intended exclusively for laboratory research. It is not intended for human or animal use, diagnosis, treatment, alleviation, or prevention of disease. The description is not medical advice. The research-use-only label and package name do not, by themselves, determine the regulatory status of the product or prove its safety or sterility.

COA on request

To enquire about a certificate of analysis (COA), send the material name, requested variant and LOT / batch number if available. Documents are not published on this page.

Request a COA by email

The button opens your email app with a prepared enquiry. You send the message yourself. peptivacomhr@gmail.com

A COA applies to a specific batch. A purity result alone does not establish sterility, absence of endotoxins or safety for use in humans or animals.

Other materials from the catalogue